| ||||||||||||||
|
|
|||||||||||||


*Department of Anesthesiology, University of Occupational and Environmental Health School of Medicine, Fukuoka, Japan, the
Second Department of Pharmacology, Nagasaki University School of Medicine, Nagasaki, Japan, and the
First Department of Physiology, University of Occupational and Environmental Health School of Medicine, Fukuoka, Japan
Address correspondence and reprint requests to Kouichiro Minami, MD, PhD, Department of Anesthesiology, University of Occupational and Environmental Health, School of Medicine, 11, Iseigaoka, Yahatanishiku, Kitakyushu, Fukuoka 8078555, Japan. Address email to kminami{at}med.uoeh-u.ac.jp
Although tramadol is widely available as an analgesic, its mechanism of antinociception remains unresolved. Serotonin (5-hydroxytryptamine, 5-HT) is a monoaminergic neurotransmitter that modulates numerous sensory, motor, and behavioral processes. The 5-HT type 2C receptor (5-HT2CR) is one of the major 5-HT receptor subtypes and is implicated in many important effects of 5-HT, including pain, feeding, and locomotion. In this study, we used a whole-cell voltage clamp to examine the effects of tramadol on 5-HT-induced Ca2+-activated Cl currents mediated by 5-HT2CR expressed in Xenopus oocytes. Tramadol inhibited 5-HT-induced Cl currents at pharmacologically relevant concentrations. The protein kinase C (PKC) inhibitor, bisindolylmaleimide I (GF109203x), did not abolish the inhibitory effects of tramadol on the 5-HT2CR-mediated events. We also studied the effects of tramadol on [3H]5-HT binding to 5-HT2CR expressed in Xenopus oocytes, and found that it inhibited the specific binding of [3H]5-HT to 5-HT2CR. Scatchard analysis of [3H]5-HT binding revealed that tramadol altered the apparent dissociation constant for binding without changing maximal binding, indicating competitive inhibition. The results suggest that tramadol inhibits 5-HT2CR function, and the mechanism of this inhibitory effect seems to involve competitive displacement of the 5-HT binding to the 5-HT2CR, rather than via activation of the PKC pathway.
IMPLICATIONS: We examined the effects of tramadol on 5-hydroxytryptamine type 2C receptor (5-HT2CR) expressed in Xenopus oocytes. Tramadol inhibited 5-HT2CR function and the specific binding of [3H]5-HT to 5-HT2CR in a competitive manner. From these data, the mechanism of the inhibitory effect on 5-HT2CR might involve the competitive displacement of 5-HT binding to the 5-HT2CR.
This article has been cited by other articles:
![]() |
R. Marincsak, B. I. Toth, G. Czifra, T. Szabo, L. Kovacs, and T. Biro The Analgesic Drug, Tramadol, Acts as an Agonist of the Transient Receptor Potential Vanilloid-1 Anesth. Analg., June 1, 2008; 106(6): 1890 - 1896. [Abstract] [Full Text] [PDF] |
||||
|